Cardiovascular Disease Risk Is Higher for People with Hepatitis C

This is from January 2016 but well worth the reprint.  We are noting more and more people being cured of HCV only to have heart attacks and strokes.  Further, some studies have shown that some DAAs affect LDL levels (bad cholesterol) such that for 6-months post treatment LDL levels can be higher than normal and this is a stroke risk.  Studies from Japan and Egypt have noted that sofosbuvir-containing treatments may have caused strokes – CDM. People with h

The Week in Review: Jan 27, 2017 – Feb 3, 2017

Friday, February 3, 2017 News Recap Hepatitis C and Rheumatic, Kidney & Heart Disease As you may remember there have been quite a few news items over the past few months about the extrahepatic effects of hepatitis C, which is more and more coming to be recognized as a multi-organ disease.  Not only is the hepatitis C virus (HCV) the cause of liver diseases in up to 170 million people worldwide, it also has many extrahepatic disease manifestation...

Direct-Acting Antivirals for HCV-Associated Rheumatic Diseases

Not only is the hepatitis C virus (HCV) the cause of liver diseases in up to 170 million people worldwide, it also has many extrahepatic disease manifestations. These include rheumatic, hematologic, cardiovascular diseases. In a review article published in Rheumatic Disease Clinics of North America, Patrice Cacoub, MD, from the Pitié-Salpêtrière University Hospital, Paris, France, and colleagues discuss the main rheumatologic diseases associated with chro